BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7182698)

  • 1. [Pharmacotherapy in severe liver failure].
    Hruby K; Kleinberger G
    Leber Magen Darm; 1982 Oct; 12(5):188-92. PubMed ID: 7182698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjusting dosage of drugs in patients with kidney or liver failure].
    Krähenbühl S
    Schweiz Med Wochenschr; 1998 Feb; 128(6):189-94. PubMed ID: 9540139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of liver congestion on hepatic drug metabolism in the rat.
    Knodell RG; Farleigh RM; Steele NM; Bond JH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-induced modifications of drug pharmacokinetics.
    Barre J; Houin G; Brunner F; Bree F; Tillement JP
    Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug dosing in chronic hepatic disease (author's transl)].
    Gugler R; Eichelbaum M
    Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics in patients with renal failure.
    Maher JF
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of circadian rhythms on the kinetics of drugs in humans.
    Baraldo M
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Principles of the pharmacokinetics and pharmacodynamics of calcium antagonists].
    Rameis H
    Wien Med Wochenschr; 1993; 143(19-20):490-500. PubMed ID: 8135031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy in the aged].
    Huber W; Turnheim K
    Wien Klin Wochenschr; 1987 Mar; 99(6):173-80. PubMed ID: 3590798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The determination of drug blood levels: when? which?].
    Galeazzi RL
    Schweiz Med Wochenschr; 1981 Mar; 111(13):466-72. PubMed ID: 7233126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy in impaired liver and kidney function].
    Galeazzi RL
    Schweiz Med Wochenschr; 1983 May; 113(20):726-32. PubMed ID: 6879125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of oxaliplatin: a critical review.
    Graham MA; Lockwood GF; Greenslade D; Brienza S; Bayssas M; Gamelin E
    Clin Cancer Res; 2000 Apr; 6(4):1205-18. PubMed ID: 10778943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy in renal failure].
    Lachhein L
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 38-40. PubMed ID: 7467564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When is determination of drug concentrations in plasma useful or necessary?].
    Roots I
    Internist (Berl); 1986 Jan; 27(1):40-52. PubMed ID: 3514516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Geriatric pharmacology. Pharmacokinetics and pharmacodynamics in the elderly. Problems with geriatric and nootropic drugs].
    Turnheim K
    Wien Klin Wochenschr; 1995; 107(12):349-56. PubMed ID: 7631505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.